192 related articles for article (PubMed ID: 32657178)
1. Improving genetic diagnostics of skeletal muscle channelopathies.
Vivekanandam V; Männikkö R; Matthews E; Hanna MG
Expert Rev Mol Diagn; 2020 Jul; 20(7):725-736. PubMed ID: 32657178
[TBL] [Abstract][Full Text] [Related]
2. Prevalence study of genetically defined skeletal muscle channelopathies in England.
Horga A; Raja Rayan DL; Matthews E; Sud R; Fialho D; Durran SC; Burge JA; Portaro S; Davis MB; Haworth A; Hanna MG
Neurology; 2013 Apr; 80(16):1472-5. PubMed ID: 23516313
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and mutation spectrum of skeletal muscle channelopathies in the Netherlands.
Stunnenberg BC; Raaphorst J; Deenen JCW; Links TP; Wilde AA; Verbove DJ; Kamsteeg EJ; van den Wijngaard A; Faber CG; van der Wilt GJ; van Engelen BGM; Drost G; Ginjaar HB
Neuromuscul Disord; 2018 May; 28(5):402-407. PubMed ID: 29606556
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients.
Brugnoni R; Maggi L; Canioni E; Verde F; Gallone A; Ariatti A; Filosto M; Petrelli C; Logullo FO; Esposito M; Ruggiero L; Tonin P; Riguzzi P; Pegoraro E; Torri F; Ricci G; Siciliano G; Silani V; Merlini L; De Pasqua S; Liguori R; Pini A; Mariotti C; Moroni I; Imbrici P; Desaphy JF; Mantegazza R; Bernasconi P
Neuromuscul Disord; 2021 Apr; 31(4):336-347. PubMed ID: 33573884
[TBL] [Abstract][Full Text] [Related]
5. Diagnostics in skeletal muscle channelopathies.
Vicino A; Brugnoni R; Maggi L
Expert Rev Mol Diagn; 2023; 23(12):1175-1193. PubMed ID: 38009256
[TBL] [Abstract][Full Text] [Related]
6. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of genetically confirmed skeletal muscle channelopathies in the era of next generation sequencing.
Vivekanandam V; Jaibaji R; Sud R; Ellmers R; Skorupinska I; Germaine L; James N; Holmes S; Mannikko R; Jayaseelan D; Hanna MG
Neuromuscul Disord; 2023 Mar; 33(3):270-273. PubMed ID: 36796140
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
Al-Ghamdi F; Darras BT; Ghosh PS
Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
Wei CJ; Wang D; Wang S; Jiao H; Hong DJ; Pu LH; Xiong H
Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):47-51. PubMed ID: 23527931
[TBL] [Abstract][Full Text] [Related]
10. Sodium Channelopathies of Skeletal Muscle.
Cannon SC
Handb Exp Pharmacol; 2018; 246():309-330. PubMed ID: 28939973
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.
Corrochano S; Männikkö R; Joyce PI; McGoldrick P; Wettstein J; Lassi G; Raja Rayan DL; Blanco G; Quinn C; Liavas A; Lionikas A; Amior N; Dick J; Healy EG; Stewart M; Carter S; Hutchinson M; Bentley L; Fratta P; Cortese A; Cox R; Brown SD; Tucci V; Wackerhage H; Amato AA; Greensmith L; Koltzenburg M; Hanna MG; Acevedo-Arozena A
Brain; 2014 Dec; 137(Pt 12):3171-85. PubMed ID: 25348630
[TBL] [Abstract][Full Text] [Related]
12. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies.
Bissay V; Van Malderen SC; Keymolen K; Lissens W; Peeters U; Daneels D; Jansen AC; Pappaert G; Brugada P; De Keyser J; Van Dooren S
Eur J Hum Genet; 2016 Mar; 24(3):400-7. PubMed ID: 26036855
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic spectrum of a Chinese cohort with SCN4A gene mutations.
Sun J; Luo S; Suetterlin KJ; Song J; Huang J; Zhu W; Xi J; Zhou L; Lu J; Lu J; Zhao C; Hanna MG; Männikkö R; Matthews E; Qiao K
Neuromuscul Disord; 2021 Sep; 31(9):829-838. PubMed ID: 33965302
[TBL] [Abstract][Full Text] [Related]
14. Double trouble in a patient with myotonia.
Hehir MK; Logigian E; Raja Rayan DL; Ciafaloni E
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417379
[TBL] [Abstract][Full Text] [Related]
15. Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies.
Meola G; Sansone V; Rotondo G; Mancinelli E
Eur J Histochem; 2003; 47(1):17-28. PubMed ID: 12685554
[TBL] [Abstract][Full Text] [Related]
16. Myotonia congenita and periodic hypokalemia paralysis in a consanguineous marriage pedigree: Coexistence of a novel CLCN1 mutation and an SCN4A mutation.
Zhao C; Tang D; Huang H; Tang H; Yang Y; Yang M; Luo Y; Tao H; Tang J; Zhou X; Shi X
PLoS One; 2020; 15(5):e0233017. PubMed ID: 32407401
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.
Platt D; Griggs R
Curr Opin Neurol; 2009 Oct; 22(5):524-31. PubMed ID: 19571750
[TBL] [Abstract][Full Text] [Related]
18. Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents.
Jarecki BW; Piekarz AD; Jackson JO; Cummins TR
J Clin Invest; 2010 Jan; 120(1):369-78. PubMed ID: 20038812
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic variability in childhood of skeletal muscle sodium channelopathies.
Yoshinaga H; Sakoda S; Shibata T; Akiyama T; Oka M; Yuan JH; Takashima H; Takahashi MP; Kitamura T; Murakami N; Kobayashi K
Pediatr Neurol; 2015 May; 52(5):504-8. PubMed ID: 25724373
[TBL] [Abstract][Full Text] [Related]
20. Changes of Resurgent Na
Huang CW; Lai HJ; Lin PC; Lee MJ
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
